Objective: Percutaneous cardiopulmonary support, a simplified form of venoarterial bypass, using totally heparin-coated circuits, has recently come into clinical use. To clarify its efficacy in postcardiotomy cardiogenic shock to aid weaning from cardiopulmonary bypass, we compared results of percutaneous cardiopulmonary support with those of left heart bypass using a centrifugal pump.Methods: We reviewed 18 patients treated between 1991 and 1998 who could not be weaned from cardiopulmonary bypass. Nine were aided by totally heparin-coated percutaneous cardiopulmonary support (PCPS group), and 9 supported by left heart bypass using a centrifugal pump (LHB group). In both groups, activated clotting time was controlled at 150–200 seconds using minimal doses of heparin as needed.Results: Weaning and survival rates were higher in the PCPS group than in the LHB group (100% vs 55.6%, and 66.7% vs 22.2%). The PCPS group had a smaller amount of blood loss and needed a smaller amount of blood components in the immediate postoperative period. One percutaneous cardiopulmonary support patient required surgical re-exploration for postoperative bleeding (11.1%), but no clinical thromboembolic event occurred in the PCPS group. In the LHB group, 5 patients underwent surgical re-exploration for postoperative bleeding (55.6%), and 2 underwent thrombus extirpation in the left ventricle (22.2%).Conclusions: Although this study was retrospective and historical backgrounds could have been involved, our data suggest that totally heparin-coated percutaneous cardiopulmonary support system appears more effective as an aid to weaning from cardiopulmonary bypass and in short-term circulatory support for patients in postcardiotomy cardiogenic shock.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Philipps SJ, Ballentine B, Slonine D, Hall J, Vandehaar J, Kongtahworn C, et at. Percutaneous initiation of cardiopulmonary bypass. Ann Thorac Surg 1983; 36: 223–5.
Shawl FA, Comanski MJ, With MH, Davis M, Punja S, Hernandez TJ. Emergency cardiopulmonary bypass support in patients with cardiac arrest in the catheterization laboratory. Cathet Cardiovasc Diag 1990; 19: 8–12.
Koyanagi H, Kitamura M, Nishida H, Hachida M, Endo M, Hashimoto A. Current strategy for severe heart failure with mechanical circulatory support. Artif Organs 1995; 19: 766–8.
Colman RW, Scott CF, Schmaier AH, Wachtfogel YT, Pixley RA, Edmunds LH Jr. Initiation of blood coagulation at artificial surfaces. Ann N Y Acad of Sci 1987; 56: 253–67.
John LCH, Rees GM, Kovacs IB. Inhibition of platelet function by heparin. An etiologic factor in post bypass hemorrhage. J Thorac Cardiovasc Surg 1993; 105: 816–22.
Golding LAR, Crouch RD, Stewart RW, Novoa R, Lytle BW, McCarthy PM, et al. Postcardiotomy centrifugal mechanical ventricular support. Ann Thorac Surg 1992; 54: 1059–64.
Anderson H, Steimle C, Shapiro M, Delius R, Chapman R, Hirschl R, et al. Extracorporeal life support for adult cardiorespiratory failure. Surgery 1993; 114: 161–73.
Matsuda H, Matsuwaka R, Kaneko M, Kobayashi T, Miyamoto K, Morisaki H, et al. Analysis of clinical factors for survival after left and biventricular bypass using centrifugal pump following open heart surgery in infants and adults. Artif Organs 1990; 14: 382–6.
Killen DA, Piehler JM, Borkon AM, Reed WA. Bio-Medicus ventricular assist device for salvage of cardiac surgical patients. Ann Thorac Surg 1991; 52: 230–5.
Pae WE, Miller CA, Matthews Y, Pierce WS. Ventricular assist devices for postcardiotomy cardiogenic shock. J Thorac Cardiovasc Surg 1992; 104: 541–3.
Shiono M, Sezai Y. Pneumatic ventricular assist device: its problems and future trends. Ann Thorac Cardiovasc Surg 1995; 2: 85–91.
Orime Y, Shindo S, Shiono M, Hata H, Yagi S, Tsukamoto S, et al. Experiences of postcardiotomy assist: pneumatic ventricular assist device or venoarterial bypass with percutaneous cardiopulmonary support. Artif Organs 1996; 20: 721–3.
Young JN, Iverson LIG, Ennix CL, Ecker RR, May IA. Biventricular support is superior to univentricular support for mechanical circulatory assistance in patients after cardiotomy. J Heart Transplant 1987; 6: 313–4.
Fosse E, Moen O, Johnson E, Semb G, Brockmeier V, Mollnes TE, et al. Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass. Ann Thorac Surg 1994; 58: 472–7.
Ovrum E, Holen EA, Tangen G, Brosstad F, Abdelnoor M, Ringdal MAL, et al. Completely heparinized cardiopulmonary bypass and reduced systemic heparin: clinical and hemostatic effects. Ann Thorac Surg 1995; 60: 365–71.
Steinberg BM, Grossi EA, Schwartz DS, McLoughlin DE, Aguinaga M, Bizekis C, et al. Heparin bonding of bypass circuits reduces cytokine release during cardiopulmonary bypass. Ann Thorac Surg 1995; 60: 525–9.
Moen O, Fosse E, Dregelid E, Brockmeier V, Adersson C, Hogasen K, et al. Centrifugal pump and heparin coating improves cardiopulmonary bypass biocompatibility. Ann Thorac Surg 1996; 62: 1134–40.
Kagisaki K, Masai T, Kadoba K, Sawa Y, Nomura F, Fukushima N, et al. Biocompatibility of heparin-coated circuits in pediatric cardiopulmonary bypass. Artificial Organs 1997; 21: 836–40.
Spencer FC, Eiseman B, Trinkle JK, Rossi NP. Assisted circulation for cardiac failure following intracardiac surgery with cardiopulmonary bypass. J Thorac Cardiovasc Surg 1965; 49: 56–73.
Ihno T, Nakagawa T, Furukawa H, Shimizu K, Egi K, Maemura T, et al. Various problems during long-term percutaneous cardiopulmonary support. Artif Organs 1997; 21: 766–71.
About this article
Cite this article
Hayashi, Y., Ohtake, S., Sawa, Y. et al. Percutaneous cardiopulmonary support with heparin-coated circuits in postcardiotomy cardiogenic shock. Jpn J Thorac Caridovasc Surg 48, 274–279 (2000). https://doi.org/10.1007/BF03218139
- heparin-coated circuits
- percutaneous cardiopulmonary support (PCPS)
- postcardiotomy cardiogenic shock
- assisted circulation